Comparative Analysis of Endovascular Treatment and Conventional Medical Management for Vertebrobasilar Artery Occlusion: A Systematic Review and Meta-Analysis - Report - MDSpire

Comparative Analysis of Endovascular Treatment and Conventional Medical Management for Vertebrobasilar Artery Occlusion: A Systematic Review and Meta-Analysis

  • By

  • Qifan Zhang

  • Qing Zhao

  • He He

  • Kuang Yan

  • Jiarui Liu

  • Shunda Liu

  • Zhimin Shi

  • Aihua Liu

  • April 20, 2026

  • 0 min

Share

Clinical Report: Comparative Analysis of Endovascular Treatment for VBAO

Overview

Revise to ensure it accurately reflects the systematic review's findings without overstating benefits.

Background

Acute vertebrobasilar artery occlusion (VBAO) is a critical condition that can lead to high mortality and severe disability. Despite advancements in endovascular therapy (EVT) for anterior circulation strokes, evidence supporting its use in VBAO has been limited. Recent trials have begun to clarify the role of EVT in this context, highlighting the need for comprehensive evaluations of its effectiveness in real-world patient populations.

Data Highlights

OutcomeEVTStandard Medical TreatmentOdds Ratio (95% CI)
Favorable functional outcome (mRS 0–3)HigherLower1.92 (1.51–2.43)
Functional independence (mRS 0–2)HigherLower1.76 (1.39–2.23)
90-day all-cause mortalityLowerHigher0.58 (0.49–0.68)
Symptomatic intracranial hemorrhageHigherLower2.57 (1.31–5.06)

Key Findings

  • EVT significantly improves favorable functional outcomes (mRS 0–3) compared to standard medical treatment.
  • Patients receiving EVT have a higher likelihood of achieving functional independence (mRS 0–2).
  • EVT is associated with a lower risk of 90-day all-cause mortality.
  • There is an increased risk of symptomatic intracranial hemorrhage with EVT.
  • Subgroup analyses indicate EVT benefits patients with NIHSS ≥10 and PC-ASPECTS <8.
  • EVT's effectiveness is less clear in elderly patients and those with mild deficits.

Clinical Implications

The findings support the use of endovascular therapy as a primary treatment for acute VBAO, particularly in patients with significant neurological deficits. Clinicians should weigh the benefits of improved functional outcomes against the risk of symptomatic intracranial hemorrhage when considering EVT for their patients.

Conclusion

Endovascular therapy represents a significant advancement in the management of acute vertebrobasilar artery occlusion, offering improved outcomes despite associated risks. Ongoing evaluation and adherence to emerging guidelines will be essential for optimizing patient care.

References

  1. Author(s)/Org, Source, Year -- Title
  2. Author(s)/Org, Source, Year -- Title
  3. Author(s)/Org, Source, Year -- Title
  4. Author(s)/Org, Source, Year -- Title
  5. New guideline expands stroke treatment for adults, offers first pediatric stroke guidance | American Heart Association
  6. Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis - ScienceDirect
  7. Outcomes of Endovascular Treatment in Patients With Vertebrobasilar Artery Occlusion Beyond 24 Hours | Neurology | JAMA Network Open | JAMA Network
  8. New guideline expands stroke treatment for adults, offers first pediatric stroke guidance | American Heart Association
  9. Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis - ScienceDirect
  10. Outcomes of Endovascular Treatment in Patients With Vertebrobasilar Artery Occlusion Beyond 24 Hours | Neurology | JAMA Network Open | JAMA Network

Original Source(s)

Related Content